During the past decade, Associated Retina Consultants conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 15 clinical trials were completed, i.e. on average, 53.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 12 clinical trials were completed. i.e. 92.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Associated Retina Consultants" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Allergan" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Allegro Ophthalmics, LLC" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associated Retina Consultants" #1 collaborator was "Bayer" with 1 trials as a collaborator, "CBCC Global Research" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "Foundation Fighting Blindness" with 1 trials as a collaborator and "Trial Runners, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Associated Retina Consultants" are "Geographic Atrophy" (7 trials), "Macular Degeneration" (7 trials), "Diabetic Macular Edema" (5 trials), "Age-Related Maculopathy" (2 trials) and "Dry Age-related Macular Degeneration" (2 trials). Many other conditions were trialed in "Associated Retina Consultants" in a lesser frequency.

Most popular intervention types in "Associated Retina Consultants" are "Drug" (25 trials), "Other" (6 trials), "Biological" (4 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Faricimab" (5 trials), "Ranibizumab" (4 trials), "Aflibercept" (2 trials) and "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Associated Retina Consultants" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Associated Retina Consultants". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Associated Retina Consultants, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Associated Retina Consultants, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".